Nubeqa and ADT treatment led to positive impacts on health-related quality of life vs placebo in metastatic hormone-sensitive prostate cancer. Among patients with with metastatic hormone-sensitive ...
Please provide your email address to receive an email when new articles are posted on . Daily oral semaglutide was tied to more weight loss vs. placebo plus lifestyle interventions in people with ...
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer One hundred sixty-two patients ...
Among adults with COPD and type 2 inflammation, having a history of cardiovascular or metabolic disease did not change ...
Vertex Pharmaceuticals has hit a snag in its efforts to follow up non-opioid pain reliever Journavx (suzetrigine). The Boston-based Big Biotech’s sodium channel inhibitor VX-993 failed to outpace ...
Polycythemia vera is a chronic myeloproliferative neoplasm characterized by erythrocytosis. Rusfertide, an injectable peptide mimetic of the master iron regulatory hormone hepcidin, restricts the ...
Correspondence to Professor Karen A Ginn, Faculty of Medicine & Health, University of Sydney SDN, Sydney, New South Wales, Australia; karen.ginn{at}sydney.edu.au Objectives To determine the effect of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback